About Sunlovis Pharmaceuticals LLP
Data last updated:
Sunlovis Pharmaceuticals LLP is a limited liability partnership (LLP) based in Hajipur, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 March 2017 and has been in existence for over 9 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAI-8723. Its GSTIN is 24ADHFS6394R1Z3 (Gujarat).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Pravinbhai Ramsangbhai Chaudhari and Pravinkumar Hemtabhai Chaudhary.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Ls:125/A Hajipur Tal: Kalol District: Gandhinagar, Gujarat, India – 382721.
As per the financials filed for FY 2024, the LLP reported a revenue of ₹38.38 Cr, a growth of 41% compared to the previous year. For the same year it recorded a net profit of ₹72.93 Lakh (net margin 1.9%) and EBITDA of ₹3.09 Cr (EBITDA margin 8.1%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 52% over five years.
The LLP has about 29 employees on its provident fund (EPFO) records.
The LLP is associated with 1 brand: Sunlovis Pharmaceuticals LLP. As per MCA filings, the LLP has open charges of ₹11.48 Cr and satisfied charges of ₹5 Cr on record. Court records list 1 case involving the LLP, including 1 filed against it; 1 case is pending.
For more details, the LLP can be reached via its website sunlovis.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressLs:125/A Hajipur Tal: Kalol District: Gandhinagar, Gujarat, India – 382721
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Sunlovis Pharmaceuticals LLP FY 2025 filings available
Sunlovis Pharmaceuticals LLP reported revenue of ₹38.38 Cr (up 41% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Sunlovis Pharmaceuticals LLP
Revenue has grown at a compounded annual rate (CAGR) of 52% over five years, including 41% growth in the latest year. EBITDA rose 164% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sunlovis Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | ₹38.38 Cr | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹72.93 Lakh | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sunlovis Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 1.9% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Sunlovis Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Sunlovis Pharmaceuticals LLP
Sunlovis Pharmaceuticals LLP is audited by JAYESH MAHESHWARI & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JAYESH MAHESHWARI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Designated Partners of Sunlovis Pharmaceuticals LLP
Sunlovis Pharmaceuticals has 6 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pravinbhai Ramsangbhai Chaudhari Also directs: Brunus Lifesciences LLP | Designated Partner | 20 Mar 2017 | 9 Years 6 Months | Current |
| Pravinkumar Hemtabhai Chaudhary Also directs: Hagios Life Sciences Private Limited | Designated Partner | 11 May 2021 | 5 Years 4 Months | Current |
| Vijaykumar Madhabhai Chaudhari Also directs: Mcway Managements Limited | Designated Partner | 20 Mar 2017 | 9 Years 6 Months | Current |
| Yogesh Babubhai Chaudhary | Designated Partner | 20 Mar 2017 | 9 Years 6 Months | Current |
| Babulal Manilal Chaudhary | Designated Partner | 20 Mar 2017 | 9 Years 6 Months | Current |
| Vipulkumar Babubhai Chaudhari Also directs: Shrriji Infrawell LLP | Designated Partner | 20 Mar 2017 | 9 Years 6 Months | Current |
Ownership and Shareholding of Sunlovis Pharmaceuticals LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sunlovis Pharmaceuticals LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Feb 2024 | Sidbi | ₹63.73 Lakh | Open |
| 31 Mar 2022 | Au Small Finance Bank Limited | ₹1.17 Cr | Open |
| 12 Jan 2022 | Au Small Finance Bank Limited | ₹9.67 Cr | Open |
| 25 Sep 2018 | The Mehsana Urban Co Operative Bank Ltd | ₹5 Cr | Satisfied |
Total charge records: 4 View all charges
Legal Cases of Sunlovis Pharmaceuticals LLP
Sunlovis Pharmaceuticals LLP has 1 court case on record: 1 filed against it. All case is pending. Status as checked on 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, GANDHINAGAR, Gujarat | Court case (DRCM) | Filed against the company by an individual | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Sunlovis Pharmaceuticals LLP
Sunlovis Pharmaceuticals operates one associated brand: Sunlovis Pharmaceuticals LLP. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and services focused on tablets, capsules, and injectables in India. | sunlovis.com |
Employees and EPFO Compliance at Sunlovis Pharmaceuticals LLP
Sunlovis Pharmaceuticals LLP has a workforce of 29 employees as of Dec 17, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sunlovis Pharmaceuticals LLP
Sunlovis Pharmaceuticals LLP has 8 designated partner changes on record since 2017: 6 appointments and 2 cessations. The latest: Pravinkumar Hemtabhai Chaudhary was appointed as Designated Partner on 11 May 2021.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Sunlovis Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sunlovis Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sunlovis Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sunlovis Pharmaceuticals LLP
Sunlovis Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24ADHFS6394R1Z3 | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sunlovis Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunlovis Pharmaceuticals LLP
Sunlovis Pharmaceuticals is an active limited liability partnership based in Hajipur, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 20 March 2017 (9+ years old) and is registered under LLPIN AAI-8723.
Sunlovis Pharmaceuticals reported revenue of ₹38.38 Cr for FY 2024 (up 41% YoY).
Sunlovis Pharmaceuticals has 6 current designated partners:
- Pravinbhai Ramsangbhai Chaudhari - Designated Partner
- Pravinkumar Hemtabhai Chaudhary - Designated Partner
- Vijaykumar Madhabhai Chaudhari - Designated Partner
- Yogesh Babubhai Chaudhary - Designated Partner
- Babulal Manilal Chaudhary - Designated Partner
- Vipulkumar Babubhai Chaudhari - Designated Partner
Sunlovis Pharmaceuticals reported a net profit of ₹72.93 Lakh (net margin 1.9%) and EBITDA of ₹3.09 Cr (EBITDA margin 8.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sunlovis Pharmaceuticals is 20% over three years and 52% over five years. In the latest year (FY 2024) revenue rose 41%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sunlovis Pharmaceuticals is 24ADHFS6394R1Z3, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Sunlovis Pharmaceuticals is AAI-8723. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Sunlovis Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Sunlovis Pharmaceuticals was incorporated on 20 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Pravinkumar Hemtabhai Chaudhary was appointed as Designated Partner on 11 May 2021. Dineshkumar Laxmanbhai Chaudhary ceased to be Designated Partner on 24 Apr 2018. Randhirkumar Madhavlal Chaudhari ceased to be Designated Partner on 24 Apr 2018. Sunlovis Pharmaceuticals has 8 designated partner changes on record in total.